DE69936773D1 - Behandlung von depression und zusammensetzungen dazu - Google Patents

Behandlung von depression und zusammensetzungen dazu

Info

Publication number
DE69936773D1
DE69936773D1 DE69936773T DE69936773T DE69936773D1 DE 69936773 D1 DE69936773 D1 DE 69936773D1 DE 69936773 T DE69936773 T DE 69936773T DE 69936773 T DE69936773 T DE 69936773T DE 69936773 D1 DE69936773 D1 DE 69936773D1
Authority
DE
Germany
Prior art keywords
depression
treatment
compositions
daily dose
folic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69936773T
Other languages
English (en)
Other versions
DE69936773T2 (de
Inventor
Alec James Coppen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scarista Ltd
Original Assignee
Scarista Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9808840A external-priority patent/GB2336534A/en
Priority claimed from GBGB9815372.9A external-priority patent/GB9815372D0/en
Application filed by Scarista Ltd filed Critical Scarista Ltd
Application granted granted Critical
Publication of DE69936773D1 publication Critical patent/DE69936773D1/de
Publication of DE69936773T2 publication Critical patent/DE69936773T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69936773T 1998-04-24 1999-04-23 Behandlung von depression und zusammensetzungen dazu Expired - Fee Related DE69936773T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9808840 1998-04-24
GB9808840A GB2336534A (en) 1998-04-24 1998-04-24 Anti-depressant - Folic Acid Combination
GB9815372 1998-07-15
GBGB9815372.9A GB9815372D0 (en) 1998-07-15 1998-07-15 Treatment of depression and pharmaceutical preparations therefor
PCT/GB1999/001268 WO1999055338A1 (en) 1998-04-24 1999-04-23 Treatment of depression and pharmaceutical preparations therefor

Publications (2)

Publication Number Publication Date
DE69936773D1 true DE69936773D1 (de) 2007-09-20
DE69936773T2 DE69936773T2 (de) 2008-04-30

Family

ID=26313533

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69936773T Expired - Fee Related DE69936773T2 (de) 1998-04-24 1999-04-23 Behandlung von depression und zusammensetzungen dazu

Country Status (14)

Country Link
EP (1) EP1071425B1 (de)
JP (1) JP2002512965A (de)
KR (1) KR100398791B1 (de)
AT (1) ATE369135T1 (de)
AU (1) AU765173B2 (de)
CA (1) CA2329665C (de)
DE (1) DE69936773T2 (de)
DK (1) DK1071425T3 (de)
ES (1) ES2292238T3 (de)
NO (1) NO20005341L (de)
NZ (1) NZ508310A (de)
PT (1) PT1071425E (de)
RU (1) RU2222329C2 (de)
WO (1) WO1999055338A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2780467B1 (de) * 2011-11-14 2018-10-17 Alfasigma S.p.A. Assays und verfahren zur auswahl eines behandlungsplans für einen patienten mit depressionen und behandlungsverfahren dafür
RU2717343C1 (ru) * 2019-03-01 2020-03-23 Евгений Владимирович Плотников Средство, обладающее цитопротекторным действием
CN113350375A (zh) * 2021-05-24 2021-09-07 北京斯利安药业有限公司 一种药用组合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2072504B (en) * 1980-03-27 1983-10-26 Coppen A J Pharmaceutical compositions
EP0089948B1 (de) * 1981-10-05 1985-08-14 COPPEN, Alec James Pharmazeutische zusammensetzungen
JP2938463B2 (ja) * 1987-10-22 1999-08-23 マサチユセツツ・インスチチユート・オブ・テクノロジー 月経前又は後期黄体期症候群の処置
IT1229517B (it) * 1989-01-31 1991-09-03 Bioresearch Spa Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
EP0714663A3 (de) * 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
GB9617990D0 (en) * 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
UA57107C2 (uk) * 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки

Also Published As

Publication number Publication date
ES2292238T3 (es) 2008-03-01
RU2222329C2 (ru) 2004-01-27
DE69936773T2 (de) 2008-04-30
CA2329665A1 (en) 1999-11-04
KR100398791B1 (ko) 2003-09-19
NO20005341D0 (no) 2000-10-23
EP1071425A1 (de) 2001-01-31
ATE369135T1 (de) 2007-08-15
JP2002512965A (ja) 2002-05-08
NZ508310A (en) 2005-03-24
AU3620399A (en) 1999-11-16
EP1071425B1 (de) 2007-08-08
WO1999055338A1 (en) 1999-11-04
CA2329665C (en) 2007-09-04
DK1071425T3 (da) 2007-12-27
PT1071425E (pt) 2007-11-16
NO20005341L (no) 2000-12-08
KR20010072579A (ko) 2001-07-31
AU765173B2 (en) 2003-09-11

Similar Documents

Publication Publication Date Title
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
TW200630123A (en) Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
MXPA02002681A (es) Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer.
HK1072541A1 (en) Trans-epicutaneous administration form for treating restless leg syndrome
ATE299740T1 (de) Kombination aus einem no-donor und einem antioxidans zur behanndlung sexueller störungen
HUP0402142A2 (hu) Kombinációs ösztrogén-gestagen készítmény és alkalmazása
DE60004797D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
IS6970A (is) Lyfjablanda á föstu formi sem felur í sér 4-sýanó-tríflúor-3-(4-flúorfenýlsúlfonýl)-2-hýdroxý-2-metýlprópíón-m-tólúidíð og PVP
BR0315927A (pt) Unidades para doses únicas diárias de melatonina
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
PT1656131E (pt) Utilização de betaína para tratar claudicação intermitente
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
DE69936773D1 (de) Behandlung von depression und zusammensetzungen dazu
EA200501223A1 (ru) Терапевтическая система, содержащая амоксициллин и клавулановую кислоту
ATE286402T1 (de) Verwendung von morinda citrifolia zur behandlung von tinnitus
TR200401810T4 (tr) Kısırlık tedavisinde fsh'ın kullanılması
MXPA04001805A (es) Nueva forma de dosificacion oral de liberacion prolongada.
DE50202865D1 (de) Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
SE0203817D0 (sv) New composition
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
ITMI980356A1 (it) Composizioni orali a basso dosaggio di proteine citotossiche
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
MXPA04011560A (es) Formulacion anti-cancer.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee